Growing expectations of a Dogecoin ETF in the United States as filings and ’40 Act’ discussions surface

Expectation that a Dogecoin ETF could appear in the United States has increased after new filings and public comments from analysts. Managers are exploring alternative regulatory routes such as the Investment Company Act of 1940 (the ’40 Act’) while markets show higher volume and price movement in anticipation.

Rules and new information

Attention is on actions by regulators and statements from analysts suggesting a launch could happen soon. Several asset managers have active submissions with the SEC and have filed amendments, but the Commission can delay approvals because of concerns about market manipulation, custody and transparency, and the process resembles earlier reviews for Bitcoin and Ethereum ETFs where signals of progress coexisted with regulatory power to modify or slow requirements.

The 40 Act path and supporters

Some applicants, including REX/REX Shares according to reports, are pursuing a product structure under the ’40 Act’ as an alternative to a standard spot ETF. That route offers a regulatory avenue that differs from typical spot ETF filings and may enable different listing approaches, but it does not eliminate a thorough SEC review and scrutiny of the product’s governance and custody arrangements.

Expected market effects, risks and implications for investors

Formal approval of a Dogecoin ETF would likely attract institutional inflows and increase trading capacity while amplifying short-term price volatility. Experience with other ETFs shows that new inflows can push prices higher, though the magnitude will depend on product design, holding limits and custody choices; investors should remember that an ETF does not remove fundamental risks, including Dogecoin’s uncapped supply, vulnerabilities in spot markets, concentration and custody challenges, and the difference between owning coins directly and obtaining exposure through a regulated product.

A Dogecoin ETF this week is possible but not certain, with signals from filings and the ’40 Act’ path raising the probability while the SEC retains authority to delay or impose conditions. Prospective investors should await the final prospectus, review custody and supply risks, and consider whether a regulated product aligns with their preferences on custody and decentralization.